Dear Sushil
In 2009 ANVISA published RDC 57, regulating the registration of API. Normative Instructions 15/09 and 3/13 list the API that need to be registered separately from finished product (drug).
RDC 57/09 only defines the requisites for registration and renewal of API. It doesn't defines how to proceed in case of variations.
Nevertheless, RDC 48/09 is the resolution that defines the variations requirements related to drugs (finished product) registrations. There is a chapter defining the requisites for changes related to the API used in the finished product.
I know it sounds a little confusing. Let me know if you have any specific question,
Regards
-------------------------------------------
ANDRE JOCHEN RAC
SAO PAULO
Brazil
-------------------------------------------
Original Message:
Sent: 09-27-2014 02:15
From: Sushil Sharma
Subject: ANVISA variation guidance
Dear Forum Members,
Does any body know the ANVISA (Brazil) guideline for API variations??? If yes plzz advise the link or guidance.
Best Regards,
-------------------------------------------
Sushil Sharma
Visakhapatnam
India
-------------------------------------------